BP1234
Letrozole
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 112809-51-5
Synonym(S): 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | BP1234-100-MG | In Stock | ₹ 24,962.45 |
BP1234 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 24,962.45
GST (18%): ₹ 4,493.241
Total Price: ₹ 29,455.691
grade
pharmaceutical primary standard
Quality Level
100
API family
letrozole
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
N#CC(C=C1)=CC=C1C(N2C=NC=N2)C3=CC=C(C#N)C=C3
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Letrozole Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,124.30 | ||
Sigma Aldrich Fine Chemicals Biosciences Letrozole United States Pharmacopeia (USP) Reference Standard | 112809-51-5 | MFCD00866241 | 200MG | -- | ₹ 47,632.80 | ||
Letrozole | -- | ₹ 11,907.50 | ||
Letrozole | -- | ₹ 14,267.35 | ||
112809-51-5 | 4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile | -- | ₹ 3,560.00 - ₹ 95,586.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Letrozole BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Letrozole Tablets
- Biochem/physiol Actions: Letrozole is a third generation nonsteroidal aromatase inhibitor. It is a competitive inhibitor of the aromatase enzyme system and thus inhibits the conversion of androgens to estrogens. Letrozole inhibits the aromatase enzyme by competitively binding to the heme of the cytochrome P450 subunit of the enzyme, resulting in a reduction of estrogen biosynthesis in all tissues.
- Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Repr. 2 - STOT RE 2
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable